Neurosteroids as regenerative agents in the brain: therapeutic implications

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Nature Reviews Endocrinology

• Publication date

  2013-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/nrendo.2013.31PMID 23438839PMCID PMC9936614
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

  2012cited by this paper
• Brain imaging in the study of Alzheimer's disease

  2012cited by this paper
• ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models

  2012cited by this paper
• Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice.

  2012cited by this paper
• Chronic Allopregnanolone Treatment Accelerates Alzheimer's Disease Development in AβPPSwePSEN1ΔE9 Mice

  2012cited by this paper
• Allopregnanolone Reinstates Tyrosine Hydroxylase Immunoreactive Neurons and Motor Performance in an MPTP-Lesioned Mouse Model of Parkinson's Disease

  2012cited by this paper
• Allopregnanolone increases the number of dopaminergic neurons in substantia nigra of a triple transgenic mouse model of Alzheimer's disease.

  2012cited by this paper
• Clinical and biomarker changes in dominantly inherited Alzheimer's disease.

  2012cited by this paper
• Lipid metabolism and neuroinflammation in Alzheimer's disease: a role for liver X receptors.

  2012cited by this paper
• Amyloid-related imaging abnormalities (ARIA) in Alzheimer’sdisease patients treated with bapineuzumab: A retrospective analysis

  2012cited by this paper
• Mechanisms Underlying the Rapid Peroxisome Proliferator-Activated Receptor-γ-Mediated Amyloid Clearance and Reversal of Cognitive Deficits in a Murine Model of Alzheimer's Disease

  2012cited by this paper
• Role of Neuroactive Steroids in the Peripheral Nervous System

  2011cited by this paper
• Neural stem cells: disposable, end-state glia?

  2011cited by this paper
• Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

  2011cited by this paper
• Epidemiology of Alzheimer disease

  2011cited by this paper
• Impaired neurosteroid synthesis in multiple sclerosis.

  2011cited by this paper
• Resolving new memories: a critical look at the dentate gyrus, adult neurogenesis, and pattern separation.

  2011cited by this paper
• Progesterone Synthesis in the Nervous System: Implications for Myelination and Myelin Repair

  2011cited by this paper
• Neuroregenerative Mechanisms of Allopregnanolone in Alzheimer’s Disease

  2011cited by this paper
• Allopregnanolone Promotes Regeneration and Reduces β-Amyloid Burden in a Preclinical Model of Alzheimer's Disease

  2011cited by this paper
• Shift in brain metabolism in late onset Alzheimer's disease: implications for biomarkers and therapeutic interventions.

  2011cited by this paper
• Amyloid‐related imaging abnormalities in amyloid‐modifying therapeutic trials: Recommendations from the Alzheimer's Association Research Roundtable Workgroup

  2011cited by this paper
• Division-coupled astrocytic differentiation and age-related depletion of neural stem cells in the adult hippocampus.

  2011cited by this paper
• Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders

  2010cited by this paper
• When neurogenesis encounters aging and disease.

  2010cited by this paper
• White matter integrity and cortical metabolic associations in aging and dementia

  2010cited by this paper
• Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

  2010cited by this paper
• Cholesterol Oxidation Products Are Sensitive and Specific Blood-Based Biomarkers for Niemann-Pick C1 Disease

  2010cited by this paper
• Neural mechanisms of ageing and cognitive decline

  2010cited by this paper
• New neurons and new memories: how does adult hippocampal neurogenesis affect learning and memory?

  2010cited by this paper
• The secretases: enzymes with therapeutic potential in Alzheimer disease

  2010cited by this paper
• Quiescent and active hippocampal neural stem cells with distinct morphologies respond selectively to physiological and pathological stimuli and aging.

  2010cited by this paper
• Allopregnanolone reverses neurogenic and cognitive deficits in mouse model of Alzheimer's disease

  2010cited by this paper
• Allopregnanolone levels are reduced in temporal cortex in patients with Alzheimer's disease compared to cognitively intact control subjects.

  2010cited by this paper
• Triple‐transgenic Alzheimer's disease mice exhibit region‐specific abnormalities in brain myelination patterns prior to appearance of amyloid and tau pathology

  2009cited by this paper
• Neurosteroid replacement therapy for catamenial epilepsy

  2009cited by this paper
• Estrogen-induced plasticity from cells to circuits: predictions for cognitive function.

  2009cited by this paper
• Adult-Born Hippocampal Dentate Granule Cells Undergoing Maturation Modulate Learning and Memory in the Brain

  2009cited by this paper
• Neuroactive steroids: an update of their roles in central and peripheral nervous system.

  2009cited by this paper
• Impaired cell proliferation in the subventricular zone in an Alzheimer's disease model

  2009cited by this paper
• Oxidative stress in NPC1 deficient cells: protective effect of allopregnanolone

  2008cited by this paper
• Impaired Adult Neurogenesis in the Dentate Gyrus of a Triple Transgenic Mouse Model of Alzheimer's Disease

  2008cited by this paper
• The healthy cell bias of estrogen action: mitochondrial bioenergetics and neurological implications.

  2008cited by this paper
• A novel site of adult doublecortin expression: neuropeptide neurons within the suprachiasmatic nucleus circadian clock

  2008cited by this paper
• Allopregnanolone impairs episodic memory in healthy women

  2008cited by this paper
• Physiological and pathological aspects of Aβ in iron homeostasis via 5'UTR in the APP mRNA and the therapeutic use of iron-chelators

  2008cited by this paper
• Allopregnanolone-induced rise in intracellular calcium in embryonic hippocampal neurons parallels their proliferative potential

  2008cited by this paper
• The LXR agonist TO901317 selectively lowers hippocampal Abeta42 and improves memory in the Tg2576 mouse model of Alzheimer's disease.

  2007cited by this paper
• Cell cycle regulation in the postmitotic neuron: oxymoron or new biology?

  2007cited by this paper
• Liver X Receptor Activation Enhances Cholesterol Loss from the Brain, Decreases Neuroinflammation, and Increases Survival of the NPC1 Mouse

  2007cited by this paper
• An in vivo correlate of exercise-induced neurogenesis in the adult dentate gyrus

  2007cited by this paper
• Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.

  2007cited by this paper
• Magnetic Resonance Spectroscopy Identifies Neural Progenitor Cells in the Live Human Brain

  2007cited by this paper
• A specific amyloid-beta protein assembly in the brain impairs memory.

  2006cited by this paper
• Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications.

  2006cited by this paper
• Pregnane X receptor (PXR) activation: A mechanism for neuroprotection in a mouse model of Niemann–Pick C disease

  2006cited by this paper
• A specific amyloid-β protein assembly in the brain impairs memory

  2006cited by this paper
• Endogenous neurosteroids regulate GABAA receptors through two discrete transmembrane sites

  2006cited by this paper
• Multiple functions of type 10 17beta-hydroxysteroid dehydrogenase.

  2005cited by this paper
• Neurosteroids: endogenous regulators of the GABAA receptor

  2005cited by this paper
• The Neurosteroid Allopregnanolone Promotes Proliferation of Rodent and Human Neural Progenitor Cells and Regulates Cell-Cycle Gene and Protein Expression

  2005cited by this paper
• High cholesterol level is essential for myelin membrane growth

  2005cited by this paper
• Multiple functions of type 10 17β-hydroxysteroid dehydrogenase

  2005cited by this paper
• Niemann–Pick type C disease involves disrupted neurosteroidogenesis and responds to allopregnanolone

  2004cited by this paper
• Allopregnanolone, a progesterone metabolite, enhances behavioral recovery and decreases neuronal loss after traumatic brain injury

  2004cited by this paper
• Predominantly neuronal expression of cytochrome P450 isoforms CYP3A11 and CYP3A13 in mouse brain.

  2003cited by this paper
• Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor.

  2002cited by this paper
• Neurogenesis may relate to some but not all types of hippocampal‐dependent learning

  2002cited by this paper
• Pxr, car and drug metabolism

  2002cited by this paper
• Neurosteroids: biochemistry and clinical significance.

  2002cited by this paper
• Disruption of neurogenesis in the subventricular zone of adult mice, and in human cortical neuronal precursor cells in culture, by amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease.

  2002cited by this paper
• Neurogenesis in the adult is involved in the formation of trace memories

  2001cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.

  2001cited by this paper
• Neurogenesis in the adult human hippocampus

  1998cited by this paper
• Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

  1997cited by this paper
• Neurosteroids: of the nervous system, by the nervous system, for the nervous system.

  1997cited by this paper
• Neurosteroids, with special reference to the effect of progesterone on myelination in peripheral nerves

  1997cited by this paper
• Neurogenesis in the dentate gyrus of the adult rat: age-related decrease of neuronal progenitor proliferation

  1996cited by this paper
• Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action.

  1988cited by this paper
• Alzheimer’s Dementia

  1985cited by this paper

• The orientation of cholesterol’s hydroxyl group affects its membrane dynamics and intracellular transport

  2026cites this paper
• Ganaxolone as a promising therapeutic agent for Alzheimer's disease: signaling pathways and mechanistic insights-a narrative review.

  2026cites this paper
• Neurosteroids, Microbiota, and Neuroinflammation: Mechanistic Insights and Therapeutic Perspectives

  2025cites this paper
• Low-dose combination of ultramicronized palmitoylethanolamide and docosahexaenoic acid on neurosteroid and neuroinflammatory dysregulation in autism spectrum disorders.

  2025cites this paper
• The Rise and Deceleration of Neuronal Excitability in Aging and Alzheimer's Disease: Mechanisms, Implications, and Therapeutic Targets.

  2025cites this paper
• Effects of gallates on 5α-reductase type 1: structure-activity relationship and implications for neurosteroid balance in neuropsychiatric disorders.

  2025cites this paper
• Progesterone for Traumatic Brain Injury, Experimental Clinical Treatment III Trial Revisited: Objective Classification of Traumatic Brain Injury With Brain Imaging Segmentation and Biomarker Levels

  2025cites this paper
• Female-specific association between the APOE E4 allele and age at diagnosis of glaucoma in UK Biobank.

  2024cites this paper
• Neurosteroids in Glioma: A Novel Therapeutic Concept

  2024cites this paper
• Neuroactive Steroids, Toll-like Receptors, and Neuroimmune Regulation: Insights into Their Impact on Neuropsychiatric Disorders

  2024cites this paper
• Emerging Evidence for Endogenous Neurosteroid Modulation of Pro-Inflammatory and Anti-Inflammatory Pathways that Impact Neuropsychiatric Disease.

  2024cites this paper
• The Effects of Neuroactive Steroids on Myelin in Health and Disease

  2024cites this paper
• The role of lipid metabolism in cognitive impairment

  2024cites this paper
• Stereospecific Properties and Intracellular Transport of Novel Intrinsically Fluorescent Neurosteroids.

  2024cites this paper
• Exploring the Dynamic Changes of Brain Lipids, Lipid Rafts, and Lipid Droplets in Aging and Alzheimer’s Disease

  2024cites this paper
• Functional Recovery in Severe Genetic Syndromes: Clinical Experience of Cell Therapy in Angelman Syndrome

  2024cites this paper
• New insights in lipid metabolism: potential therapeutic targets for the treatment of Alzheimer’s disease

  2024cites this paper
• Monomeric Amyloid Peptide-induced Toxicity in Human Oligodendrocyte Cell Line and Mouse Brain Primary Mixed-glial Cell Cultures: Evidence for a Neuroprotective Effect of Neurosteroid 3α-O-allyl-allopregnanolone

  2024cites this paper
• The GABA system, a new target for medications against cognitive impairment—Associated with neuroactive steroids

  2023cites this paper
• Allopregnanolone pleiotropic action in neurons and astrocytes: calcium signaling as a unifying mechanism

  2023influential citation
• Zuranolone – synthetic neurosteroid in treatment of mental disorders: narrative review

  2023cites this paper
• 5 -Alpha-dihydroxyprogesterone may contribute to perceptual processing and attention of the cases with relapsing remitting multiple sclerosis

  2023cites this paper
• Disease stage-dependent changes in brain levels and neuroprotective effects of neuroactive steroids in Parkinson's disease.

  2023cites this paper
• Inhibition of human macrophage activation via pregnane neurosteroid interactions with toll-like receptors: Sex differences and structural requirements

  2022cites this paper
• Allopregnanolone: Metabolism, Mechanisms of Action, and Its Role in Cancer

  2022cites this paper
• Alfaxalone anaesthesia increases brain derived neurotrophic factor levels and preserves postoperative cognition by activating pregnane-X receptors: an in vitro study and a double blind randomised controlled trial

  2022cites this paper
• Allopregnanolone: Regenerative therapeutic to restore neurological health

  2022cites this paper
• Amyloid β, Lipid Metabolism, Basal Cholinergic System, and Therapeutics in Alzheimer’s Disease

  2022cites this paper
• Lack of placental neurosteroid alters cortical development and female somatosensory function

  2022cites this paper
• Relationship between adult subventricular neurogenesis and Alzheimer’s disease: Pathologic roles and therapeutic implications

  2022cites this paper
• Exploratory imaging outcomes of a phase 1b/2a clinical trial of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: Structural effects and functional connectivity outcomes

  2022cites this paper
• Allopregnanolone suppresses glioblastoma survival through decreasing DPYSL3 and S100A11 expression.

  2022cites this paper
• Ethanol, Neurosteroids and Cellular Stress Responses: Impact on Central Nervous System Toxicity, Inflammation and Autophagy.

  2021cites this paper
• Positive GABAA receptor modulating steroids and their antagonists: Implications for clinical treatments

  2021cites this paper
• Allopregnanolone: An overview on its synthesis and effects

  2021cites this paper
• Progesterone and Allopregnanolone Neuroprotective Effects in the Wobbler Mouse Model of Amyotrophic Lateral Sclerosis

  2021cites this paper
• Alfaxalone activates Human Pregnane-X Receptors with greater efficacy than Allopregnanolone: an in-vitro study with implications for neuroprotection during anesthesia

  2020cites this paper
• Insights into Disease-Associated Tau Impact on Mitochondria

  2020cites this paper
• Steroids and Alzheimer’s Disease: Changes Associated with Pathology and Therapeutic Potential

  2020cites this paper
• Allopregnanolone Promotes Neuronal and Oligodendrocyte Differentiation In Vitro and In Vivo: Therapeutic Implication for Alzheimer’s Disease

  2020cites this paper
• Alternatives to amyloid for Alzheimer's disease therapies—a symposium report

  2020cites this paper
• Midlife Chronological and Endocrinological Transitions in Brain Metabolism: System Biology Basis for Increased Alzheimer’s Risk in Female Brain

  2020cites this paper
• Pharmacokinetic and Pharmacodynamic Analysis of Alfaxalone Administered as a Bolus Intravenous Injection of Phaxan in a Phase 1 Randomized Trial

  2020cites this paper
• Progesterone receptor-mediated actions and the treatment of central nervous system disorders: an up-date of the known and the challenge of the unknown.

  2020cites this paper
• Inhibitors of cellular stress overcome acute effects of ethanol on hippocampal plasticity and learning.

  2020influential citation
• The Role of Estradiol in Traumatic Brain Injury: Mechanism and Treatment Potential

  2020cites this paper
• Neuroactive Steroids in Hypoxic–Ischemic Brain Injury: Overview and Future Directions

  2020cites this paper
• Safety, tolerability, and pharmacokinetics of allopregnanolone as a regenerative therapeutic for Alzheimer's disease: A single and multiple ascending dose phase 1b/2a clinical trial

  2020cites this paper
• Lipid and Lipid Raft Alteration in Aging and Neurodegenerative Diseases: A Window for the Development of New Biomarkers

  2019cites this paper
• Cerebroprotection by progesterone following ischemic stroke: Multiple effects and role of the neural progesterone receptors.

  2019cites this paper
• Experimental traumatic brain injury results in estrous cycle disruption, neurobehavioral deficits, and impaired GSK3&bgr;/&bgr;‐catenin signaling in female rats

  2019cites this paper
• The impact of sensory and motor enrichment on the epigenetic control of steroidogenic-related genes in rat hippocampus.

  2019cites this paper
• Brain intracrinology of allopregnanolone during pregnancy and hormonal contraception

  2019cites this paper
• GABA(A) receptor-targeted drug development -New perspectives in perioperative anesthesia

  2019cites this paper
• Neurosteroid Actions in Memory and Neurologic/Neuropsychiatric Disorders

  2019cites this paper
• Enhanced remyelination during late pregnancy: involvement of the GABAergic system

  2019cites this paper
• Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence

  2019cites this paper
• Prospects for the application of mesenchymal stem cells in Alzheimer's disease treatment.

  2019cites this paper
• Allopregnanolone as a Therapeutic to Regenerate the Degenerated Brain

  2019cites this paper
• TSPO Ligands Boost Mitochondrial Function and Pregnenolone Synthesis

  2019cites this paper
• Progesterone effects on the oligodendrocyte linage: all roads lead to the progesterone receptor

  2019influential citation
• Neurosteroids as regulators of neuroinflammation.

  2019cites this paper
• Mitochondria modulatory effects of new TSPO ligands in a cellular model of tauopathies

  2019cites this paper
• Allopregnanolone Reverses Bioenergetic Deficits in Female Triple Transgenic Alzheimer’s Mouse Model

  2019cites this paper
• Pleiotropic actions of allopregnanolone underlie therapeutic benefits in stress-related disease

  2019cites this paper
• A Rationale for Allopregnanolone Treatment of Alcohol Use Disorders: Basic and Clinical Studies.

  2019cites this paper
• GABA-A receptor modulating steroids in acute and chronic stress; relevance for cognition and dementia?

  2019cites this paper
• Impacts of stress on reproductive and social behaviors.

  2018cites this paper
• Expression and activity profiling of the steroidogenic enzymes of glucocorticoid biosynthesis and the fdx1 co‐factors in zebrafish

  2018cites this paper
• White Matter and Cognition in Traumatic Brain Injury

  2018cites this paper
• Agathisflavone, a flavonoid derived from Poincianella pyramidalis (Tul.), enhances neuronal population and protects against glutamate excitotoxicity

  2018cites this paper
• Overview of the Molecular Steps in Steroidogenesis of the GABAergic Neurosteroids Allopregnanolone and Pregnanolone

  2018cites this paper
• Pre-Menopause, Menopause and Beyond

  2018cites this paper
• Understanding the role of steroids in typical and atypical brain development: Advantages of using a “brain in a dish” approach

  2018cites this paper
• Neurosteroids in Pain Management: A New Perspective on an Old Player

  2018cites this paper
• Endogenous neurosteroids influence synaptic GABAA receptors during postnatal development

  2018cites this paper
• Neurosteroid allopregnanolone reduces ipsilateral visual cortex potentiation following unilateral optic nerve injury

  2018influential citation
• The Dynamics of Neurosteroids and Sex-Related Hormones in the Pathogenesis of Alzheimer’s Disease

  2018cites this paper
• Allopregnanolone and Progesterone in Experimental Neuropathic Pain: Former and New Insights with a Translational Perspective

  2018cites this paper
• Identification of steroidal derivatives inhibiting the transformations of allopregnanolone and estradiol by 17β-hydroxysteroid dehydrogenase type 10.

  2018cites this paper
• Translocator protein ligand, YL-IPA08, attenuates lipopolysaccharide-induced depression-like behavior by promoting neural regeneration

  2018cites this paper
• Evidence for effective structure‐based neuromodulatory effects of new analogues of neurosteroid allopregnanolone

  2018cites this paper
• From Menopause to Aging: Endocrine and Neuroendocrine Biological Changes

  2018cites this paper
• Current advances in transdermal delivery of drugs for Alzheimer's disease

  2017cites this paper
• Steroids and steroid-metabolizing enzymes in the nervous system : Special focus on cell survival and sex hormone synthesis

  2017cites this paper
• A Role of Endogenous Progesterone in Stroke Cerebroprotection Revealed by the Neural-Specific Deletion of Its Intracellular Receptors

  2017cites this paper
• Open-Label Allopregnanolone Treatment of Men with Fragile X-Associated Tremor/Ataxia Syndrome

  2017cites this paper
• Melatonin: Protection against age-related cardiac pathology

  2017cites this paper
• The translocator protein ligand XBD173 improves clinical symptoms and neuropathological markers in the SJL/J mouse model of multiple sclerosis.

  2017cites this paper
• Discovery of Imidazoquinazolinone Derivatives as TSPO Ligands Modulating Neurosteroidogenesis and Cellular Bioenergetics in Neuroblastoma Cells Expressing Amyloid Precursor Protein

  2017cites this paper
• Potential Treatments for Alzheimer’s Disease

  2017cites this paper
• Nestorone® as a Novel Progestin for Nonoral Contraception: Structure-Activity Relationships and Brain Metabolism Studies

  2017cites this paper
• Voluntary ethanol consumption reduces GABAergic neuroactive steroid (3α,5α)3‐hydroxypregnan‐20‐one (3α,5α‐THP) in the amygdala of the cynomolgus monkey

  2017cites this paper
• Allopregnanolone promotes proliferation and differential gene expression in human glioblastoma cells

  2017cites this paper
• Allopregnanolone and its analog BR 297 rescue neuronal cells from oxidative stress-induced death through bioenergetic improvement.

  2017cites this paper
• Overexpression of the 18 kDa translocator protein (TSPO) in the hippocampal dentate gyrus produced anxiolytic and antidepressant-like behavioural effects.

  2017cites this paper
• Fragile X-associated tremor/ataxia syndrome — features, mechanisms and management

  2016cites this paper
• Oestrogens and Progestagens: Synthesis and Action in the Brain

  2016cites this paper
• Progestins and carcinogenesis

  2016cites this paper
• Naturally occurring marine steroid 24-methylenecholestane-3β,5α,6β,19-tetraol functions as a novel neuroprotectant.

  2016cites this paper